Prof. Dr. Ilker UCKAY | Infektiologie | Best Researcher Award

Prof. Dr. Ilker UCKAY | Infektiologie | Best Researcher Award

Prof. Dr. med, at Balgrist, Switzerland.

Prof. Dr. med. Ilker Uçkay is a renowned physician-scientist specializing in infectious diseases and infection control. Born on May 10, 1970, in Uzwil, Switzerland, he has made significant contributions to the field of orthopedic infections and antibiotic stewardship. With expertise in multiple languages, including German, French, Turkish, English, and Italian, Prof. Uçkay has collaborated with international teams to advance research and clinical practice.

Professional Profile

Google Scholar

🎓 Education

– *Federal Diploma of Medicine*, University of Zurich, Switzerland (1995) 💊– *Doctor Thesis*, University of Zurich, Switzerland (1996) 🔬– *Swiss Federal Diploma in Internal Medicine* (2001) 💼– *Swiss Federal Diploma in Infectious Diseases* (2006) 🧬– *Advanced Course of Epidemiology*, London School of Hygiene and Tropical Medicine (2006) 📚– *Habilitation*, University of Geneva (2012) 🎓– *Titular Professorship*, University of Zurich (2019)

💼 Experience

– *Attending Lead Infectiology*, Balgrist University Hospital, Switzerland (2018-present) 💼– *Attending*, Geneva University Hospitals, Switzerland (2009-2018) 🏥– *Resident*, Geneva University Hospitals, Switzerland (2001-2009) 👨‍⚕️– *Head of Unit for Clinical and Applied Research*, Balgrist University Hospital, Switzerland (2018-2024)

🔬 Research Interests

– *Orthopedic Infections*: prevention, diagnosis, and treatment 🔬– *Antibiotic Stewardship*: optimizing antibiotic use in orthopedic infections 💊– *Infection Control*: reducing healthcare-associated infections

🏆 Awards

– *Best Paper in Epidemiology*, ICAAC Programme Committee Award (2010) 🏆– *Best Poster*, Annual Meeting of the Swiss Society for Orthopaedic Surgery (2013) 📚– *Best Research*, Annual Meeting of the Swiss Society for Orthopaedic Surgery (2013) 🔬– *Prix Marko Müller*, Annual Meeting of the Swiss Society for Orthopaedic Surgery (2015) 🏆– *Neviaser Award*, Journal of Shoulder and Elbow Surgery (2023) 🏆– *Fellow in the Royal Academy of Physicians*, London, England (2024)

📚Top Noted  Publications

– Short Duration of Antibiotic Prophylaxis in Gustilo Grade III Open Extremities Fractures 🔬
– Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae 🧬
– No need for search of asymptomatic urinary tract colonization before elective hip and knee arthroplasty 🏥
– Administration of antibiotic agents before intraoperative sampling in orthopedic infections 💊
– Short postsurgical antibiotic therapy for spinal infections 🔬
– A postoperative initially inadequate antibiotic treatment is not associated with an increased risk of therapy failures 📊

Conclusion

Prof. Ilker Uçkay’s impressive research record, leadership roles, and awards make him a strong candidate for the Best Researcher Award. His contributions to orthopedic infections and antibiotic stewardship have significant clinical implications. By further emphasizing translational research, global health, and mentorship, Prof. Uçkay could strengthen his application and demonstrate his potential for continued excellence in research.

Nitin Pal Kalia | Infectious diseases | Best Researcher Award

Dr. Nitin Pal Kalia | Infectious diseases | Best Researcher Award

Assistant Professor at  NIPER HYDERABAD, India

Changmin Shi is a Postdoctoral Research Associate at Brown University, specializing in energy materials mechanics and thermal energy management. With extensive experience in materials science and engineering, he has contributed to groundbreaking research on high-energy-density lithium-sulfur batteries and innovative solutions for energy storage and thermal regulation. His work is aimed at advancing battery performance, enhancing materials for space thermoregulation, and developing recyclable battery technologies. Changmin’s research has garnered significant funding and continues to shape the future of energy-efficient systems.

 

Professional Profiles:

Education🎓

Brown University (2023–Present) – Postdoctoral Research Associate, School of Engineering University of Maryland (2019–2023) – Ph.D. in Materials Science and Engineering, Dissertation on Lithium-Sulfur Batteries Columbia University (2017–2019) – M.S. in Materials Science and Engineering, Research on Flexible Lithium-ion Batteries University of Science and Technology Beijing (2013–2017) – B.Eng. in Metallurgical Engineering, Research on PEM Fuel Cell Materials

Experience🔬

Postdoctoral Research Associate at Brown University, School of Engineering (2023–Present) Ph.D. Researcher at University of Maryland, focusing on lithium-sulfur batteries and energy materials (2019–2023) Graduate Research Assistant at Columbia University, specializing in flexible energy storage systems (2017–2019) Research Assistant at University of Science and Technology Beijing, focusing on PEM fuel cell materials (2013–2017)

Awards and Honors🏅

“Battery-Driven Systems Enabled Materials Thermoregulation” funding from LiquidMetal, $250,000 (2025–2027) “Blocking Li Metal Dendrites with Piezoelectric Solid Polymer Electrolytes” funding, $90,013 (2023–2024) Initiative for Sustainable Energy Funding for “Hierarchically-Structured Coatings for Thermal Energy Management,” $90,774 (Proposal submission) Research Grants and Proposals from NSF and other funding agencies

Research Focus🔬

Battery Technology – Development of safe, high-energy-density batteries with advanced materials Thermal Energy Management – Innovations in space thermoregulation and passive radiation cooling systems  Recyclable Energy Systems – Novel approaches to sustainable, recyclable battery technologies  Energy Materials Mechanics – Investigating mechanical properties of energy materials, including elasticity, plasticity, fracture toughness, and flexibility

✍️Publications Top Note :

“Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus”
This study, published in Journal of Antimicrobial Chemotherapy (2012), identifies capsaicin as an effective inhibitor of the NorA efflux pump, reducing the invasion of Staphylococcus aureus. The research was co-authored by NP Kalia and others.

“Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection”
Published in Proceedings of the National Academy of Sciences (2017), this paper investigates how targeting the synthetic lethality of terminal respiratory oxidases can clear Mycobacterium tuberculosis infections, offering potential therapeutic strategies.

“Sulfur-rich 2-mercaptobenzothiazole and 1, 2, 3-triazole conjugates as novel antitubercular agents”
This article in the European Journal of Medicinal Chemistry (2014) discusses the synthesis and antitubercular properties of sulfur-rich conjugates, with NP Kalia contributing to the study.

“Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors”
A 2008 publication in Bioorganic & Medicinal Chemistry, which presents piperine analogs as inhibitors of the NorA efflux pump in Staphylococcus aureus, a key player in antibiotic resistance.

“Protective efficacy of piperine against Mycobacterium tuberculosis”
In this 2014 Tuberculosis journal article, the protective effect of piperine against Mycobacterium tuberculosis is evaluated, with NP Kalia contributing to the study.

“Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus”
Published in Journal of Medical Microbiology (2011), this study explores the potential of piperine to inhibit the MdeA efflux pump, which is involved in antibiotic resistance in Staphylococcus aureus.

“Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit”
In this 2012 Indian Journal of Microbiology article, methyl caffeate isolated from Solanum torvum fruit is evaluated for its antimicrobial and antimycobacterial properties.

“Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis”
A study in EMBO Molecular Medicine (2021), where the dual inhibition of terminal oxidases is shown to eradicate antibiotic-tolerant Mycobacterium tuberculosis.

Conclusion

Changmin Shi is undoubtedly a strong contender for the Best Researcher Award. His innovative contributions to energy materials, mechanical devices for material characterization, and high-energy-density battery systems are transformative in both the academic and industrial research spaces. His proactive approach in securing funding, initiating research ideas, and collaborating with key industry players positions him as a future leader in materials science and engineering.